United Therapeutics | UTHR - Current Liabilities


United Therapeutics reported $546.3M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Amarin USD 182.23M 3.71M Sep/2025
Ardelyx USD 83.39M 1.67M Sep/2025
Baxter International USD 2.97B 805M Dec/2025
Bayer EUR 28.96B 825M Sep/2025
BioCryst Pharmaceuticals USD 190.24M 13.08M Sep/2025
Biogen USD 3.35B 59.4M Dec/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Emergent BioSolutions USD 651.3M 12.7M Dec/2023
Esperion Therapeutics USD 359.03M 60.24M Sep/2025
Gilead Sciences USD 11.81B 485M Dec/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
Halozyme Therapeutics USD 177.09M 660.14M Dec/2025
Insmed USD 468.87M 51.66M Dec/2025
Ionis Pharmaceuticals USD 903.46M 6.22M Sep/2025
J&J USD 54.13B 3.26B Dec/2025
Lexicon Pharmaceuticals USD 34.84M 75.86M Jun/2025
Moderna USD 1.99B 306M Dec/2025
Omeros USD 85.5M 2.28M Jun/2025
Pfizer USD 36.6B 1.13B Sep/2025
PTC Therapeutics USD 968.43M 102.18M Dec/2025
Regeneron Pharmaceuticals USD 4.37B 56.7M Dec/2025
Sangamo BioSciences USD 47.66M 1.9M Jun/2025
Sarepta Therapeutics USD 921.42M 1.48M Sep/2025
Teva Pharmaceutical Industries USD 13.46B 1.96B Dec/2025
United Therapeutics USD 546.3M 19.2M Sep/2025
Vertex Pharmaceuticals USD 3.86B 614.1M Dec/2025